Cumberland Pharmaceuticals (CPIX) FCF Margin (2010 - 2026)

Cumberland Pharmaceuticals has disclosed FCF Margin across 17 years of filings, most recently posting 2356.62% for Q2 2026.

• In Q2 2026, FCF Margin fell 257125.0% year-over-year to 2356.62%; the TTM figure through Jun 2026 stood at 10.78% (down 3301.0% YoY), while the FY2025 annual figure was 10.86%, up 1265.0% from the prior year.
• FCF Margin came in at 2356.62% for Q2 2026 at Cumberland Pharmaceuticals, down from 4.24% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 214.63% in Q2 2025 to a low of 2356.62% in Q2 2026.
• Average FCF Margin over 5 years is 109.85%, with a median of 7.83% recorded in 2023.
• Year-over-year, FCF Margin surged 22339 bps in 2025 and plunged 257125 bps in 2026.
• Over 5 years, FCF Margin stood at 41.56% in 2022, then sank by 74 bps to 10.6% in 2023, then jumped by 72 bps to 18.23% in 2024, then tumbled by 100 bps to 0.02% in 2025, then plunged by 10656415 bps to 2356.62% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 2356.62% in Q2 2026, 4.24% in Q1 2026, and 0.02% in Q4 2025.